Derivative liabilities (Tables)
|
9 Months Ended |
May 31, 2025 |
|---|
| Derivative liabilities |
|
| Schedule of assumptions used to determine the fair value of the warrant |
| | | | | | | | | | | | | Original | | | | | | Risk-free | | | | | Exercise | | Market | | Expected | | interest | | Expected | | | price | | price | | volatility | | rate | | life | Issuance date | | $ | | $ | | % | | % | | [years] | January 19, 2023 | | 7,600.50 | | 7,600.50 | | 100 | | 3.4 | | 3 | February 17, 2023 | | 7,654.50 | | 8,167.50 | | 100 | | 4.0 | | 3 | April 19, 2023 | | 7,614.00 | | 7,492.50 | | 75 | | 3.9 | | 3 | June 16, 2023 | | 7,222.50 | | 7,425.00 | | 75 | | 4.1 | | 3 | August 2, 2023 | | 7,249.50 | | 6,885.00 | | 75 | | 4.8 | | 3 | September 20, 2023 | | 7,344.00 | | 5,940.00 | | 75 | | 4.8 | | 3 | January 14, 2025 | | 20.64 | | 19.74 | | 99 | | 4.4 | | 5.5 |
| | | | | | | | | | | Number of | | Weighted average | | | Revised | | warrants | | remaining | | | Exercise price | | outstanding | | contractual life | Issuance date | | $ | | # | | [years] | January 19, 2023 | | 1,950.20 | | 412 | | 0.64 | February 17, 2023 | | 1,950.20 | | 353 | | 0.72 | April 19, 2023 | | 1,950.20 | | 283 | | 0.88 | June 16, 2023 | | 1,950.20 | | 367 | | 1.04 | August 2, 2023 | | 1,950.20 | | 368 | | 1.17 | September 20, 2023 | | 1,950.20 | | 277 | | 1.31 | January 14, 2025 | | 20.64 | | 235,320 | | 5.13 |
|
| Schedule of movements in derivative financial liabilities |
| | | | | | | As at | | As at | | | May 31, | | August 31, | | | 2025 | | 2024 | | | $ | | $ | Opening balance | | 30,564 | | 5,558,822 | Additions | | 3,188,389 | | 765,733 | Effect on fair value of repricing of warrants | | — | | 896,458 | Change in estimate of fair value | | (1,394,542) | | (7,190,449) | Closing balance | | 1,824,411 | | 30,564 |
|
| Series A Convertible Preferred Shares |
|
| Derivative liabilities |
|
| Schedule of movements in derivative financial liabilities |
| | | | | | | As at | | As at | | | May 31, | | August 31, | | | 2025 | | 2024 | | | $ | | $ | Opening balance | | 694,232 | | — | Fair value at issuance | | — | | 12,744,593 | Deferred loss at issuance | | — | | (8,737,194) | Revaluation at the end of the period | | (1,258,951) | | (10,336,357) | Amortization of the deferred loss during the period | | — | | 7,325,187 | Accelerated amortization of the deferred loss during the period | | 804,676 | | — | Voluntary conversions to Voting Common Shares during the period [Note 19] | | (136,689) | | (301,997) | Forced conversions to Voting Common Shares during the period [Note 19] | | (103,268) | | — | Closing balance | | — | | 694,232 |
|
| Series B Convertible Preferred Shares |
|
| Derivative liabilities |
|
| Schedule of movements in derivative financial liabilities |
| | | | | | | As at | | As at | | | May 31, | | August 31, | | | 2025 | | 2024 | | | $ | | $ | Opening balance | | 1,455,594 | | — | Fair value at issuance | | — | | 6,888,006 | Deferred loss at issuance | | — | | (2,841,008) | Forced conversions to Voting Common Shares during the period [Note 19] | | (195,806) | | — | Revaluation at the end of the period | | (2,035,649) | | (4,642,780) | Amortization of the deferred loss during the period | | — | | 1,674,778 | Accelerated amortization of the deferred loss during the period | | 789,633 | | 376,598 | Closing balance | | 13,772 | | 1,455,594 |
|